Weill Cornell Medicine has received $4.2 million to study how the immune system in some people infected with HIV can keep the virus under control, which could lead to new therapies.
Weill Cornell Medicine received a $1.5 million grant to develop new approaches for predicting the spread of cancer cells to the bone in men with prostate cancer, using tumor samples taken at early stages of the disease.
Alistair Hayden, a professor of practice in public and ecosystem health and a former division chief at the California Governor’s Office of Emergency Services, comments on Canadian wildfire smoke reaching the U.S. and how to improve a national response to future smoke waves.
A decline in estrogen during menopause causes changes in body fat distribution and associated cardiovascular and metabolic disease, but a new Cornell-led study identifies potential therapies that might one day reverse these unhealthy shifts.
A new consortium co-led by Weill Cornell Medicine has been awarded a five-year, $31 million grant from the NIH’s National Institute of Allergy and Infectious Diseases to accelerate the development of better treatment regimens for tuberculosis.
Through its new Public Health Essentials online certificate program, Cornell seeks to help leaders proactively address today’s global health challenges.
Greater understanding of beneficial characteristics of the human brain, such as flexibility and reliability, will help Wenbo Tang develop therapies for human diseases – and to improve AI systems.
The newest episode of a podcast hosted by Entrepreneurship at Cornell, Startup Cornell, features Tim Barry ‘93, the chair and CEO of VillageMD, and this year’s Cornell Entrepreneur of the Year. Entrepreneurship at Cornell will honor Barry on April 11 and 12 during the Celebration event on campus.
